Mainline Biosciences (China) Overview
- Year Founded
-
2021
- Status
-
Private
- Latest Deal Type
-
Series A1
- Investors
-
3
Mainline Biosciences (China) General Information
Description
Developer of novel peptide drugs designed for oncology treatment. The company focuses on the field of innovative peptide drugs through computational chemistry and AI-assisted peptide design, providing patients with innovative treatment drugs.
Contact Information
Corporate Office
- Room 409, 4th Floor, Building C, Innovation Center
- No. 34 Xiangshan Avenue, Cuiheng New District
- Zhongshan, Guangdong 528449
- China
Corporate Office
- Room 409, 4th Floor, Building C, Innovation Center
- No. 34 Xiangshan Avenue, Cuiheng New District
- Zhongshan, Guangdong 528449
- China
Mainline Biosciences (China) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A1) | 21-Jul-2024 | Completed | Clinical Trials - General | |||
| 1. Early Stage VC (Series A) | 09-Nov-2022 | Completed | Clinical Trials - General |
Mainline Biosciences (China) Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Taikun Fund | Venture Capital | Minority | ||
| Fuho Capital | Venture Capital | Minority | ||
| SAFE Pharmaceutical | VC-Backed Company | Minority |
Mainline Biosciences (China) FAQs
-
When was Mainline Biosciences (China) founded?
Mainline Biosciences (China) was founded in 2021.
-
Where is Mainline Biosciences (China) headquartered?
Mainline Biosciences (China) is headquartered in Zhongshan, China.
-
What industry is Mainline Biosciences (China) in?
Mainline Biosciences (China)’s primary industry is Drug Discovery.
-
Is Mainline Biosciences (China) a private or public company?
Mainline Biosciences (China) is a Private company.
-
What is Mainline Biosciences (China)’s current revenue?
The current revenue for Mainline Biosciences (China) is .
-
How much funding has Mainline Biosciences (China) raised over time?
Mainline Biosciences (China) has raised $13.8M.
-
Who are Mainline Biosciences (China)’s investors?
Taikun Fund, Fuho Capital, and SAFE Pharmaceutical have invested in Mainline Biosciences (China).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process